DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Overview Fund Activity
Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

144 hedge funds and large institutions have $1.13B invested in Dicerna Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 52 increasing their positions, 53 reducing their positions, and 37 closing their positions.

Holders
144
Holders Change
-25
Holders Change %
-14.79%
% of All Funds
3.18%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
14
Increased
52
Reduced
53
Closed
37
Calls
$292K
Puts
$1.15M
Net Calls
-$857K
Net Calls Change
-$190K

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$71.1M
2
RI
2
RTW Investments
New York
$128M
3
BlackRock
3
BlackRock
New York
$92.9M
4
ACM
4
Aquilo Capital Management
California
$22.7M
5
Invesco
5
Invesco
Georgia
$8.93M

Top Sellers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$4.55M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$48.3M
3
AG
3
Artal Group
Luxembourg
$0
4
BM
4
Bridger Management
New York
$30.9M
5
EC
5
EcoR1 Capital
California
$61.5M
Name Market Value Shares Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$11.4M 618,085 -7,825 -1%
Invesco
27
Invesco
Georgia
$8.93M 486,225 +443,858 +1,048%
EMFAT
28
Emerald Mutual Fund Advisers Trust
Pennsylvania
$8.85M 482,001 -179,051 -27%
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$8.4M 457,106 -107,805 -19%
Carson Wealth (CWM LLC)
30
Carson Wealth (CWM LLC)
Nebraska
$8.08M 216,565 – –
Nuveen Asset Management
31
Nuveen Asset Management
Illinois
$7.21M 392,210 +868 +0.2%
PAM
32
Panagora Asset Management
Massachusetts
$7.07M 385,067 +382,511 +14,965%
Charles Schwab
33
Charles Schwab
California
$6.51M 354,276 +31,381 +10%
PAI
34
Palo Alto Investors
California
$6.1M 331,813 – –
UBS AM
35
UBS AM
Illinois
$6.02M 327,642 +269,359 +462%
Two Sigma Investments
36
Two Sigma Investments
New York
$5.94M 323,468 -234,139 -42%
PHP
37
Parkman Healthcare Partners
Connecticut
$5.53M 300,805 +60,805 +25%
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$5.42M 295,175 +109,325 +59%
ACP
39
Acuta Capital Partners
California
$4.71M 256,500 -131,000 -34%
Bank of New York Mellon
40
Bank of New York Mellon
New York
$4.6M 250,386 -42,068 -14%
Adage Capital Partners
41
Adage Capital Partners
Massachusetts
$4.59M 250,000 -150,000 -38%
Marshall Wace
42
Marshall Wace
United Kingdom
$4.55M 247,695 -732,175 -75%
Schroder Investment Management Group
43
Schroder Investment Management Group
United Kingdom
$4.54M 229,039 +119,349 +109%
Axa
44
Axa
France
$4.39M 238,872 +238,872 New
VOYA Investment Management
45
VOYA Investment Management
Georgia
$4.27M 232,710 +16,766 +8%
Assenagon Asset Management
46
Assenagon Asset Management
Luxembourg
$3.52M 191,758 +191,758 New
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$3.44M 187,757 +139,226 +287%
IHAM
48
Integral Health Asset Management
New York
$3.4M 185,000 -15,000 -8%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$2.96M 160,849 +41,579 +35%
Bank of America
50
Bank of America
North Carolina
$2.89M 157,304 +39,845 +34%
1
2
3 4 5